Linked Life Data

19414346

Source:http://linkedlifedata.com/resource/pubmed/id/19414346

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-5-5
pubmed:abstractText
It has been previously shown that gefitinib reverses breast cancer resistance protein (BCRP)-mediated drug resistance. Here, the impact of BCRP on gefitinib-mediated inhibition in epidermal growth factor receptor (EGFR) signaling is evaluated.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1059-65
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Pharmacological interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling.
pubmed:affiliation
Division of Chemotherapy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't